Sort   by:  
 Page size 
UnknownFinnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study.
Not available
S-EPMC6969418 | biostudies-literature
UnknownSubtle neuropsychiatric and neurocognitive changes in hereditary gelsolin amyloidosis (AGel amyloidosis).
Not available
S-EPMC4121541 | biostudies-literature
UnknownCommon origin of the gelsolin gene variant in 62 Finnish AGel amyloidosis families.
Not available
S-EPMC5838978 | biostudies-literature
UnknownCHCHD10 variant p.(Gly66Val) causes axonal Charcot-Marie-Tooth disease.
Not available
S-EPMC4821082 | biostudies-literature
UnknownTargeted next-generation sequencing reveals further genetic heterogeneity in axonal Charcot-Marie-Tooth neuropathy and a mutation in HSPB1.
Not available
S-EPMC3953916 | biostudies-literature
UnknownClinical features of facioscapulohumeral muscular dystrophy 2.
Not available
S-EPMC2974464 | biostudies-literature
UnknownFGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.
Not available
S-EPMC7568343 | biostudies-literature
UnknownMutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy.
Not available
S-EPMC4863565 | biostudies-literature
Sort   by:  
 Page size